TD Cowen Maintains Twist Bioscience(TWST.US) With Buy Rating, Maintains Target Price $58
Twist Bioscience Analyst Ratings
Wolfe Research Initiates Twist Bioscience(TWST.US) With Buy Rating, Announces Target Price $60
Twist Bioscience Initiated With an Outperform at Wolfe Research
Twist Bioscience Analyst Ratings
TD Cowen Maintains Twist Bioscience(TWST.US) With Buy Rating, Maintains Target Price $58
Barclays Maintains Overweight on Twist Bioscience, Lowers Price Target to $52
Twist Bioscience Price Target Raised to $54.00/Share From $50.00 by Scotiabank
Scotiabank Maintains Twist Bioscience(TWST.US) With Buy Rating, Raises Target Price to $54
A Quick Look at Today's Ratings for Twist Bioscience(TWST.US), With a Forecast Between $35 to $58
Twist Bioscience Analyst Ratings
Baird Maintains Outperform on Twist Bioscience, Raises Price Target to $48
Twist Bioscience Is Maintained at Market Perform by Leerink Partners
Twist Bioscience Analyst Ratings
Leerink Partners Maintains Twist Bioscience(TWST.US) With Hold Rating, Raises Target Price to $48
Positive Outlook and Strong Pricing Strategy Justify Buy Rating for Twist Bioscience
Barclays Maintains Twist Bioscience(TWST.US) With Buy Rating, Maintains Target Price $55
Barclays Sticks to Their Buy Rating for Twist Bioscience (TWST)
Baird Maintains Twist Bioscience(TWST.US) With Buy Rating, Maintains Target Price $46
Twist Bioscience Analyst Ratings